Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 1/20 | 0.32 |
| ▸ | MMP1 | P03956 | 2/20 | 0.30 |
| ▸ | MMP2 | P08253 | 2/20 | 0.30 |
| ▸ | METAP1 | P53582 | 1/20 | 0.30 |
| ▸ | MMP3 | P08254 | 1/20 | 0.30 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | MMP9 | P14780 | 1/20 | 0.30 |
| ▸ | MMP8 | P22894 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13636101 | 0.86 | SMPD1 (0.36) | PIK3CD | |
| SCHEMBL8407485 | 0.86 | SMPD1 (0.36) | PIK3CD | |
| Phosphoric Acid SCHEMBL11590026 | 0.78 | MMP1 (0.31) | MMP1MMP2MMP3CA12CA1 | |
| SCHEMBL21291945 | 0.77 | METAP1 (0.32) | METAP1 | |
| SCHEMBL6647953 | 0.76 | PIK3CD (0.37) | PIK3CD | |
| SCHEMBL26207037 | 0.76 | TDP1 (0.38) | — | |
| SCHEMBL8079525 | 0.76 | LPAR5 (0.46) | — | |
| SCHEMBL4319783 | 0.75 | LAP3 (0.46) | MMP1METAP1MMP8 | |
| SCHEMBL497286 | 0.75 | LAP3 (0.39) | MMP1MMP2METAP1MMP3CA12 | |
| SCHEMBL7152549 | 0.75 | LAP3 (0.33) | METAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11248011-B2 | Phosphorus-based releasing agent, optical polymerizable composition comprising same and preparation thereof | SKC CO., LTD. (KR) | 2022-02-15 | — | — | US | claimed |
| US-20190263846-A1 | PHOSPHORUS-BASED RELEASING AGENT, OPTICAL POLYMERIZABLE COMPOSITION COMPRISING SAME AND PREPARATION THEREOF | SK PUCORE CO., LTD. (KR) | 2019-08-29 | — | — | US | claimed |
| EP-3530684-A1 | PHOSPHORUS-BASED RELEASING AGENT, OPTICAL POLYMERIZABLE COMPOSITION COMPRISING SAME AND PREPARATION THEREOF | SKC Co., Ltd. (KR) | 2019-08-28 | — | — | EP | claimed |
| US-11753547-B2 | Near-infrared absorbing composition, near-infrared absorbing film, and image sensor for solid-state imaging element | Konica Minolta, Inc. (JP) | 2023-09-12 | — | — | US | disclosed |
| CN-110183603-B | Phosphorus-containing release agent, optical polymerizable composition containing same, and method for producing same | SKC株式会社 | 2023-04-07 | — | — | CN | disclosed |
| US-11248011-B2 | Phosphorus-based releasing agent, optical polymerizable composition comprising same and preparation thereof | SKC CO., LTD. (KR) | 2022-02-15 | — | — | US | disclosed |
| US-20190263846-A1 | PHOSPHORUS-BASED RELEASING AGENT, OPTICAL POLYMERIZABLE COMPOSITION COMPRISING SAME AND PREPARATION THEREOF | SK PUCORE CO., LTD. (KR) | 2019-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190263846-A1 | PHOSPHORUS-BASED RELEASING AGENT, OPTICAL POLYMERIZABLE COMPOSITION COMPRISING SAME AND PREPARATION THEREOF | PMM2, PGM2, IPMK | PIK3CD 182/4885MMP1 2866/4885MMP2 3709/4885 |
| US-11248011-B2 | Phosphorus-based releasing agent, optical polymerizable composition comprising same and preparation thereof | PMM2, PGM2, IPMK | PIK3CD 182/4885MMP1 2866/4885MMP2 3709/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.